Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
0-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin BindingYoshida-Moriguchi, Takako ; Yu, Liping ; Stalnaker, Stephanie H. ; Davis, Sarah ; Kunz, Stefan ; Madson, Michael ; Oldstone, Michael B. A. ; Schachter, Harry ; Wells, Lance ; Campbell, Kevin P.Science (American Association for the Advancement of Science), 2010-01, Vol.327 (5961), p.88-92 [Periódico revisado por pares]American Association for the Advancement of ScienceTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical TrialSosne, Gabriel ; Kleinman, Hynda K ; Springs, Clark ; Gross, Robert Hollis ; Sung, Jihye ; Kang, ShinwookInternational journal of molecular sciences, 2022-12, Vol.24 (1), p.554 [Periódico revisado por pares]Switzerland: MDPITexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
011 The british childhood visual impairment and blindness study (BCVIS2): 1-year outcomesTeoh, L ; Rahi, J ; Solebo, A ; Cumberland, PArchives of disease in childhood, 2018-12, Vol.103 (Suppl 2), p.A5-A5 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
076 Increased physiological responses to threat in Duchenne muscular dystrophy: a potential CNS outcome measureMaresh, Kate E ; Papageorgiou, Andriani ; Ridout, Deborah ; Harrison, Neil A ; Mandy, William ; Skuse, David ; Muntoni, FrancescoJournal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A36-A36 [Periódico revisado por pares]London: BMJ Publishing Group LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
078 Myotonic dystrophy service redesign: report on a patient engagement eventDent, James ; Akintade, Sola ; Kelly, Phillip ; Roberts, Mark ; Lilleker, JamesJournal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A36-A37 [Periódico revisado por pares]London: BMJ Publishing Group LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
0865 SLEEP PARAMETERS OF PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHYEwing, T ; Ahn, M ; Kumar, K ; Vaughn, B ; Roth, H ; Fan, ZSleep (New York, N.Y.), 2017-04, Vol.40 (suppl_1), p.A321-A321 [Periódico revisado por pares]US: Oxford University PressTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
0980 Sleep And Activity Rhythms In Children With Duchenne Muscular DystrophyHartman, A G ; Smagula, S F ; Bendixen, RSleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A372-A372 [Periódico revisado por pares]US: Oxford University PressTexto completo disponível |
8 |
Material Type: magazinearticle
|
![]() |
1 First drug therapy for Duchenne muscular dystrophyRT (Los Angeles, Calif.), 2016-10, Vol.29 (10), p.42Anthem Systems LLCTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
1-Palmitoyl-2-(9′-oxononanoyl)-sn-glycero-3-phosphocholine, an Oxidized Phospholipid, Accelerates Finnish Type Familial Gelsolin Amyloidosis in VitroMahalka, Ajay K ; Maury, C. Peter J ; Kinnunen, Paavo K. JBiochemistry (Easton), 2011-06, Vol.50 (22), p.4877-4889 [Periódico revisado por pares]United States: American Chemical SocietyTexto completo disponível |
10 |
Material Type: Capítulo de Livro
|
![]() |
10 - Muscular Dystrophies and Allied Disorders I: Duchenne and Becker Muscular DystrophyMuscle Biopsy, 2021, p.214-236Elsevier LtdTexto completo disponível |